Author

Takafumi Hagiwara

Observed names: T Hagiwara, T. Hagiwara

Institution: Takarazuka City Hospital

Observed institutions: Kagoshima University, Matsubara Mayflower Hospital, Kagoshima University Hospital, Takarazuka City Hospital

OpenAlex ID: A5043209626

Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level

2009 · Keiko Funahashi, Satoru Koyano, et al. · Modern Rheumatology · 47

HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells

2004 · Naomichi Arima, Kosei Arimura, et al. · Experimental Hematology · 29

Successful Treatment of Good Syndrome with Cytomegalovirus Duodenoenteritis Using a Combination of Ganciclovir and Immunoglobulin with High Anti-Cytomegalovirus Antibody Titer

2004 · Nobuyuki Koriyama, Osamu Fukumoto, et al. · The American Journal of the Medical Sciences · 21

Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS‐RA

2004 · Kosei Arimura, Naomichi Arima, et al. · European Journal Of Haematology · 14

Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis:Post-hocsubgroup analysis of the ORIGAMI study

2022 · Takanori Azuma, Kenta Misaki, et al. · Modern Rheumatology · 4

Thu0099 the Time Required to Escalate the Dosage of Methotrexate to Therapeautic Levels Affects the Treatment Success Achieved During Phase I of the Treatment Algorithm for Rheumatoid Arthritis Recommended by the European League Against Rheumatism

2020 · T. Hagiwara, K. Kamada, et al. · Annals of the Rheumatic Diseases · 1

Ab0669 Real-world Data on Rheumatoid Arthritis Management: Two-year Continuity Rates of Phase-1 Treatment and Factors Influencing Retention Rates: a Longitudinal Observational Study

2024 · T. Hagiwara, Y. Yano, et al. · Annals of the Rheumatic Diseases

Ab0312 Association Between Disease Activity and Changes in Fibrosis-4 Index Level in Patients With Rheumatoid Arthritis Treated With Methotrexate for a Short Period

2023 · N. Namura, K. Kamada, et al. · Annals of the Rheumatic Diseases

Fri0472 Comparison of the Therapeutic Efficacy of Daily Versus Weekly Dose of Teriparatide for Preventing Bone Fracture in Patients With Osteoporosis – a Single Centre, Prospective Open-label Study

2019 · Takafumi Hagiwara, Kazuya Kamada, et al. · Annals of the Rheumatic Diseases

AB0310 Using treat-to-target strategy by determining physical disability and glucocorticoid reduction strongly influence functional remission in rheumatoid arthritis

2018 · T. Hagiwara, K. Kamada, et al. · Annals of the Rheumatic Diseases

SAT0068 The time until performing tight control as a treat-to-target strategy and the tolerability of methotrexate strongly influence the achievement of clinical remission in rheumatoid arthritis

2017 · T Hagiwara, K Kamada, et al. · Annals of the Rheumatic Diseases

SNP algorithms for prediction of efficacy and adverse events of abatacept (ABT)

2012 · James E Middleton, Tsukasa Matsubara, et al. · Arthritis Research & Therapy

Works count: 12

Citation count: 116

H-index: 4

I10-index: 4